South Korea · Delayed Price · Currency is KRW ROKIT Healthcare Company Description
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea.
The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD).
It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellular matrix; EpiTem, a reconstructed human epidermis model; and anti-aging supplements, as well as operates a tissue bank.
The company was formerly known as ROKIT Inc. and changed its name to ROKIT Healthcare Inc. in 2018.
The company was incorporated in 2012 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2012 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 72 |
| CEO | Seok-hwan Yoo |
Contact Details
Address: Digital-ro 10-gil 9 Seoul, 08514 South Korea | |
| Phone | 82 1 899 7296 |
| Website | rokithealthcare.com |
Stock Details
| Ticker Symbol | 376900 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Seok-hwan Yoo | Chief Executive Officer |
| Yong-gyu Lee | Chief Financial Officer |